Top compounds associated with response to P2RY2


Feature Type Standardized
Nominal ANOVA
mRNA neratinib CTRPv2 pan-cancer AAC 0.2 5e-08
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 8e-08
mRNA Gefitinib CTRPv2 pan-cancer AAC 0.2 2e-07
mRNA PD318088 CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA linifanib GDSC1000 pan-cancer AAC 0.2 2e-07
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 8e-07
mRNA CI-1040 GDSC1000 pan-cancer AAC 0.18 9e-07
mRNA ATRA GDSC1000 pan-cancer AAC 0.18 1e-06
mRNA lapatinib GDSC1000 pan-cancer AAC 0.23 2e-06
mRNA Erlotinib CTRPv2 pan-cancer AAC 0.17 3e-06
Download CSV